# Catalpa Ventures

Catalpa Ventures is a Single Family Office based in Grevenmacher, Luxembourg.

## Overview

- **Organization type:** Single Family Office
- **Headquarters:** Grevenmacher, Luxembourg
- **Region:** Europe
- **Address:** 17, Rue de Flaxweiler, L-6776 Grevenmacher, Luxembourg
- **Founded:** 2017
- **Assets under management:** 100 (Altss estimate)
- **Website:** catalpa.vc
- **LinkedIn:** https://lu.linkedin.com/company/catalpa-ventures

## Regulatory record

- **Reports private funds:** No

## About

Catalpa Ventures was established in 2017 by members of the Goergen family. Dr. Thomas Goergen, Christian Goergen, and Adrian Goergen serve as founding partners alongside Prof. Dr. Silke R. Sperling. The family office maintains its headquarters in Grevenmacher, Luxembourg. The firm targets early-stage health-tech investments in DACH, Benelux, and selected European hubs. It allocates across direct co-investments and fund commitments in private equity and venture capital. Portfolio holdings include Noah Labs, whose vocal-biomarker platform detects cardiac decompensation, and Remi Health, which embeds diagnostic testing into payer and pharma workflows. Catalpa also maintains exposure to North American opportunities through selective co-investments alongside external managers. The office employs a compact team of investment and operations professionals. It lists no additional offices beyond the Luxembourg headquarters. Catalpa Health Fund I serves as the primary deployment vehicle. In 2024 Prof. Dr. Silke R. Sperling moderated events hosted by the Falling Walls Foundation. Catalpa's structure separates the family's direct investment mandate from external LP commitments through a dedicated fund vehicle. This architecture allows the principals to maintain control over capital allocation while accessing third-party capital for larger health-tech rounds.

## Sectors

- Digital Health
- Healthcare Services
- FinTech
- Robotics & Automation
- Workflow Automation

## People

- Dr. rer. pol. Thomas Goergen — Founding & Managing Partner
- Prof. Dr. med. Silke R. Sperling — Founding & Managing Partner
- Dr.-Ing. Christian Goergen — Founding & Managing Partner
- Willibrord Ehses — Managing Partner
- Adrian Goergen — Principal

## Questions

### Who runs investment decisions at Catalpa Ventures?

Dr. Thomas Goergen, Prof. Dr. Silke R. Sperling, and Dr. Christian Goergen serve as founding and managing partners responsible for investment strategy and LP relations.

### How does Catalpa source proprietary deal flow?

The firm leverages prior relationships from Mangrove Capital Partners and academic networks at Charité and the Max Planck Institute to identify health-tech opportunities.

### Is Catalpa structured as a single family office or does it operate more like a venture firm?

Catalpa operates as a single family office that deploys both proprietary capital and third-party commitments through Catalpa Health Fund I.

### Does Catalpa participate in fund commitments or only direct deals?

The firm executes both direct co-investments and commitments to external venture funds focused on health technology.

### What investment stages does Catalpa typically target?

Catalpa targets pre-seed through Series A rounds with initial checks between €300,000 and €1.5 million.

### What is Catalpa's known posture on co-investments alongside external GPs?

Catalpa reserves follow-on capital to participate alongside external managers in health-tech companies that have progressed beyond the initial ticket size.

## Related profiles

- [California Technology Ventures](https://altss.com/profile/california-technology-ventures)
- [CIV](https://altss.com/profile/civ-compagnia-per-l-innovazione-e-per-i-valori)

---

Last updated: 2026-08-10T15:54:10.904Z

Canonical page: https://altss.com/profile/catalpa

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology